Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial
2024-12 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial
Schmalstieg-Bahr, K.; Gladstone, D. J.; Hummers, E. ; Suerbaum, J.; Healey, J. S.; Zapf, A. & Köster, D. et al. (2024)
European Journal of General Practice, 30(1) pp. 2327367. DOI: https://doi.org/10.1080/13814788.2024.2327367
Documents & Media
Details
- Authors
- Schmalstieg-Bahr, Katharina; Gladstone, David J.; Hummers, Eva ; Suerbaum, Johanna; Healey, Jeff S.; Zapf, Antonia; Köster, Denise; Werhahn, Stefanie M.; Wachter, Rolf
- Abstract
- Atrial fibrillation (AF) is a common treatable risk factor for stroke. Screening for paroxysmal AF in general practice is difficult, but biomarkers might help improve screening strategies.
- Issue Date
- December-2024
- Journal
- European Journal of General Practice
- Organization
- Institut für Allgemeinmedizin
- ISSN
- 1381-4788; 1751-1402
- eISSN
- 1751-1402
- Language
- English
